Phase I/II study of osimertinib with bevacizumab in...

  • Main
  • 2019 / 3
  • Phase I/II study of osimertinib with bevacizumab in...
Clinical Lung Cancer 2019 / 3

Phase I/II study of osimertinib with bevacizumab in EGFR-mutated, T790M-positive patients with progressed EGFR-TKIs: West Japan Oncology Group 8715L (WJOG8715L)

Akamatsu, Hiroaki, Teraoka, Shunsuke, Morita, Satoshi, Katakami, Nobuyuki, Tachihara, Motoko, Daga, Haruko, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2019.03.002
Date:
March, 2019
File:
PDF, 1.62 MB
2019
Conversion to is in progress
Conversion to is failed